XT
EW icon

XTX Topco’s Edwards Lifesciences EW Stock Holding History

XTX Topco’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,558
Closed -$354K – 3440
2025
Q3 		$354K Buy
+4,558
New +$356K 0.02% 1377
2025
Q2 		– Sell
-27,622
Closed -$2M – 2588
2025
Q1 		$2M Buy
27,622
+6,722
+32% +$481K 0.1% 259
2024
Q4 		$1.55M Sell
20,900
-32,396
-61% -$2.27M 0.13% 141
2024
Q3 		$3.52M Buy
53,296
+21,814
+69% +$1.58M 0.25% 31
2024
Q2 		$2.91M Buy
+31,482
New +$2.79M 0.25% 51
2023
Q4 		– Sell
-8,020
Closed -$556K – 1739
2023
Q3 		$556K Buy
+8,020
New +$644K 0.09% 335
2023
Q1 		– Sell
-8,194
Closed -$611K – 1393
2022
Q4 		$611K Buy
8,194
+252
+3% +$19.4K 0.13% 215
2022
Q3 		$656K Buy
+7,942
New +$764K 0.16% 140
2022
Q2 		– Sell
-3,005
Closed -$354K – 927
2022
Q1 		$354K Buy
+3,005
New +$337K 0.16% 220

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

XTX Topco's EW Position: Q4 2025 in Review

XTX Topco sold out of Edwards Lifesciences (EW) in Q4 2025, closing a stake of 4,558 shares — an estimated $354K sold.

XTX Topco first reported a position in EW in Q1 2022 and held it in 9 quarters. The position peaked at $3.52M in Q3 2024. 1,313 funds tracked by Wall St. Rank hold EW as of Q4 2025.

  • XTX Topco reported no remaining Edwards Lifesciences position as of Q4 2025 after selling out during the quarter.
  • XTX Topco sold 4,558 Edwards Lifesciences shares in Q4 2025, an estimated $354K.
  • XTX Topco first reported a position in Edwards Lifesciences in Q1 2022 and held it in 9 quarters.
  • XTX Topco's Edwards Lifesciences position peaked at $3.52M in Q3 2024.
  • 1,313 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.